Form 4: GoodRx Director Kelly J. Kennedy Reports Acquisition of 28,398 Shares of Class A Common Stock

Kelly J. Kennedy, a director of GoodRx Holdings, Inc., reported acquiring 28,398 shares of Class A common stock on June 6, 2024, through restricted stock units.

Summary

• On June 6, 2024, Kelly J. Kennedy, a director of GoodRx Holdings, Inc., acquired 28,398 shares of Class A common stock.
• The acquisition was in the form of restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Class A common stock.
• The RSUs vest in full on the earlier of (i) the one-year anniversary of June 6, 2024, and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.
• Following the transaction, Kennedy directly owns 28,398 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a director's stock acquisition, which can be seen as a positive sign of confidence, but it's not overwhelmingly positive.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the RSUs is contingent upon continued service, suggesting an ongoing commitment from the director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of shares by a director could positively influence shareholder sentiment.

Key Dates